Fibrates News and Research

RSS
Patients taking the lipid-lowering medications have a relatively low risk of developing rhabdomyolysis

Patients taking the lipid-lowering medications have a relatively low risk of developing rhabdomyolysis

Zetia co-administered with Fenofibrate significantly reduced LDL ("bad") cholesterol in mixed hyperlipidemia patients

Zetia co-administered with Fenofibrate significantly reduced LDL ("bad") cholesterol in mixed hyperlipidemia patients

First Approval in Europe of Ezetimibe/Simvastatin for treatment of elevated cholesterol

First Approval in Europe of Ezetimibe/Simvastatin for treatment of elevated cholesterol